论文部分内容阅读
Prostate cancer (PCa) represents the most common malignancy in adult males with an estimated number of 280 000 newly diagnosed cases only in the United States in 2015.1 Due to the introduction of PSA in clinical practice,the majority of the patients are currently diagnosed with organ-confined and sometimes indolent disease.